A significant difference was observed in p16, p21 and p53 expression between leiomyosarcoma and leiomyoma, supporting the hypothesis that these genes may be the predicted target genes that are commonly enriched in sarcoma genesis pathways (Table III). Here, CDKN2A is linked to leiomyosarcoma.